ClinicalTrials.gg
CompletedNCT03315819BANKARTUpdated Dec 22, 2025

Anterior Capsulo-labral Reinsertion by Arthroscopic Approach Versus Immobilization

An interventional study of Bankart repair and Immobilization interne rotation in Bankart Lesion, sponsored by University Hospital, Lille. Completed at 1 site in France. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by University Hospital, Lille · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Mar 2014, registered Oct 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The risk of recurrence and chronic instability after an initial episode of anterior glenohumeral dislocation is high, the risk is higher the younger the patient is.

Most patients with recurrences develop this instability during the first 2 years.

Several studies have shown that an initial arthroscopic surgical treatment (Bankart intervention) decreased the risk of recurrence and therefore of chronic instability, but this attitude is not usual in France and none randomized study comparing intervention of arthroscopic Bankart and immobilization was published by a French team.

The primary objective was to evaluate at 2 years the efficacy on the rate of recurrent instability of the first-line arthroscopic repair of prior capsulo-labral lesions compared to conservative treatment by immobilization for patients under 25 years having an initial episode of anterior glenohumeral dislocation

Material and method : We conducted a randomized controlled, open-label, parallel-group study (conservative treatment group by immobilizing VS surgical treatment group) in patients aged 18 to 25 with anterior glenohumeral primo luxation. Patients were clinically reassessed at 2 years with functional scores (WOSI, DuplayWalch, DASH), mobility and instability recurrence.

Hypothesis: reduction of the recurrence rate in the surgically treated group

02

Conditions studied

  • Bankart Lesion

Browse trials for

Keywords

  • glenohumeral dislocation
  • Arthroscopic
  • capsular lesions
03

In context

Shoulder Dislocation

105 studies on the registry are indexed under Shoulder Dislocation; 22 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 71 interventional studies indexed under Shoulder Dislocation.

Browse Shoulder Dislocation studies →

Lead sponsor

University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with inclusive on the day of dislocation.
  • First episode of anterior glenohumeral dislocation without associated humeral fracture confirmed by a standard radiograph.

Exclusion criteria

Exclusion Criteria:

  • Dislocation without trauma, in a context of hyper laxity with a Beighton score ≥4 / 97.8. In these patients post-dislocation MRI was performed in the Robinson study, which found no capsulo-labral lesion.
  • Bone glenoid defect> 25% at the scanner (Bony Bankart).
  • Delay greater than 15 days between luxation and surgical treatment
  • Against indication to anesthesia
  • Pregnant or nursing women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Bankart repair

    Arthroscopic repair of anterior capsulo-labral lesions using the Bankart technique. The procedure must be performed within 15 days of dislocation.

    Procedure: Bankart repair

  • Active comparator
    Immobilization interne rotation

    Immobilization of the shoulder during 3 weeks

    Procedure: Immobilization interne rotation

Interventions

  • ProcedureBankart repair

    Arthroscopic repair of anterior capsulo-labral lesions using the Bankart technique.

  • ProcedureImmobilization interne rotation

    Immobilisation in rotation Internal (Dujarrier) 3 weeks then rehabilitation

06

What researchers measure

Primary outcomes

  1. Number of occurrence of a recurrence during the follow-up period of 2 years

    Time frame: at 2 years

Secondary outcomes

  1. Number of recidivism of dislocation with the necessity of reduction by a third person

    Time frame: at 3 months, 6 months, 1 years and 2 years

  2. number of episodes of subluxations reported by the patient at the interview

    Time frame: at 3 months, 6 months, 1 years and 2 years

  3. Goniometer measurement of the angle in the ankle joint

    Time frame: at 3 months, 6 months, 1 years and 2 years

  4. Walch Duplay Score

    Auto questionnaire designed to measure the impact of shoulder instability, activity, pain mobility.total point up to 100 : excellent, good, medium, poor

    Time frame: at 3 months, 6 months, 1 years and 2 years

  5. Disabilities of the Arm, Shoulder and Hand (DASH) Score

    Auto questionnaire designed to measure the quality of life of patients.

    Time frame: at 3 months, 6 months, 1 years and 2 years

  6. Western Ontario Shoulder Instability (WOSI) Score.

    Auto questionnaire designed to measure the impact of shoulder instability on the quality of life of patients. percentage of lifestyle, emotion, physical symptome.

    Time frame: at 3 months, 6 months, 1 years and 2 years

  7. Likert Scale

    Overall patient satisfaction

    Time frame: at 2 years

  8. The duration of work stoppage

    Time frame: at 2 years

  9. Time lapse - resumption of sports activities and level of sport practiced

    Time frame: At 6 months, 1 years and 2 years

07

Study locations

1 site
  • Hôpital Roger Salengro
    Lille, 59000, France
08

References and documents

Publications

  • Pouges C, Hardy A, Vervoort T, Amouyel T, Duriez P, Lalanne C, Szymanski C, Deken V, Chantelot C, Upex P, Maynou C. Arthroscopic Bankart Repair Versus Immobilization for First Episode of Anterior Shoulder Dislocation Before the Age of 25: A Randomized Controlled Trial. Am J Sports Med. 2021 Apr;49(5):1166-1174. doi: 10.1177/0363546521996381. Epub 2021 Mar 11. PubMed 33705240 ↗
  • Pouges C, Boutry M, Maynou C, Chantelot C, Vervoort T, Amouyel T, Lalanne C, Malandri-Ghipponi P. Arthroscopic Bankart Repair Versus Immobilization for a First Episode of an Anterior Shoulder Dislocation Before the Age of 25 Years: A Randomized Controlled Trial With 6-Year Follow-up. Am J Sports Med. 2025 Aug;53(10):2289-2297. doi: 10.1177/03635465251350151. Epub 2025 Jul 2. PubMed 40605377 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2014 to primary completion in Mar 2019, 59 months.

Of 39 non-industry interventional studies with no phase under Shoulder Dislocation, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 59 months is above that.

Counting every sponsor, half of 39 studies reached it within 22 months; a quarter within 11 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2017
First posted
Oct 20, 2017
StartActual
Mar 27, 2014
Primary completionActual
Mar 26, 2019
CompletionActual
Mar 26, 2019
Last update
Dec 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03315819
Responsible party
Sponsor
First posted
Oct 20, 2017
Start date
Mar 27, 2014
Primary completion
Mar 26, 2019
Completion
Mar 26, 2019
Last update
Dec 22, 2025

Study contacts

Cécile Pougès, Dr
principal investigator · CHRU LILLE

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion